Related references
Note: Only part of the references are listed.Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis
Sebastien Sanges et al.
ANNALS OF THE RHEUMATIC DISEASES (2023)
NT-proBNP, hs-cTnT, and CRP predict the risk of cardiopulmonary outcomes in systemic sclerosis: Findings from the Canadian Scleroderma Research Group
Mayank Jha et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2022)
Utility of cytokines CXCL4, CXCL8 and GDF15 as biomarkers in systemic sclerosis
Jose E. Oller-Rodriguez et al.
MEDICINA CLINICA (2022)
Thoracic Involvement in Systemic Autoimmune Rheumatic Diseases: Pathogenesis and Management
Elena De Zorzi et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2022)
TIMP-1: A Circulating Biomarker for Pulmonary Hypertension Diagnosis Among Chronic Obstructive Pulmonary Disease Patients
Wenjun He et al.
FRONTIERS IN MEDICINE (2022)
An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients
Barbara Ruaro et al.
DIAGNOSTICS (2022)
Capillaroscopy and Immunological Profile in Systemic Sclerosis
Sevdalina Nikolova Lambova et al.
LIFE-BASEL (2022)
Soluble markers of B cell activation suggest a role of B cells in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertension
Sebastien Sanges et al.
FRONTIERS IN IMMUNOLOGY (2022)
Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension
Christoph Tabeling et al.
FRONTIERS IN IMMUNOLOGY (2022)
An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers
Joana Santos-Gomes et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)
Marc Humbert et al.
EUROPEAN HEART JOURNAL (2022)
Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension
Henriette Didriksen et al.
FRONTIERS IN IMMUNOLOGY (2022)
The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease
Elisabetta Zanatta et al.
PHARMACEUTICALS (2022)
The impact of anti-endothelial cell antibodies (AECAs) on the development of blood vessel damage in patients with systemic lupus erythematosus: the preliminary study
Pawel Cieslik et al.
RHEUMATOLOGY INTERNATIONAL (2022)
Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: machine learning on proteomics from the DETECT cohort
Yasmina Bauer et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
The LPS induced pyroptosis exacerbates BMPR2 signaling deficiency to potentiate SLE-PAH
Yanjiang Xing et al.
FASEB JOURNAL (2021)
Association of serum CCL20 levels with pulmonary vascular involvement and primary biliary cholangitis in patients with systemic sclerosis
Tetsuya Ikawa et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2021)
Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs)
Mattia Bellan et al.
PHARMACEUTICALS (2021)
Predicting the Risk of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: A Chinese Systemic Lupus Erythematosus Treatment and Research Group Cohort Study
Jingge Qu et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review
Laurence Leber et al.
PULMONARY CIRCULATION (2021)
Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review
Cosimo Bruni et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)
Pulmonary arterial hypertension associated with primary Sjogren's syndrome: a multicentre cohort study from China
Jieying Wang et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
Paola Di Benedetto et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Pulmonary arterial hypertension in connective tissue disorders: Pathophysiology and treatment
Elisabetta Zanatta et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2019)
Endothelins in cardiovascular biology and therapeutics
Neeraj Dhaun et al.
NATURE REVIEWS CARDIOLOGY (2019)
Prevalence, Treatment, and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic Sclerosis
Amber Young et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Pulmonary Hypertension Associated with Connective Tissue Disease
Hossam Fayed et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
TGF and BMPRII signalling pathways in the pathogenesis of pulmonary arterial hypertension
Birger Tielemans et al.
DRUG DISCOVERY TODAY (2019)
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study
Silvia Bosello et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2019)
Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features
Anna-Maria Hoffmann-Vold et al.
RMD OPEN (2019)
Serum uric acid as a marker of disease risk, severity, and survival in systemic sclerosis-related pulmonary arterial hypertension
Catherine E. Simpson et al.
PULMONARY CIRCULATION (2019)
Mild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality
Philipp Douschan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
The multiple functions and mechanisms of osteopontin
Mehmet Arif Icer et al.
CLINICAL BIOCHEMISTRY (2018)
PDGF in organ fibrosis
Barbara Mara Klinkhammer et al.
MOLECULAR ASPECTS OF MEDICINE (2018)
Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review
Isabel S. Bazan et al.
RESPIRATORY MEDICINE (2018)
CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis
Anna-Maria Hoffmann-Vold et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Mild Pulmonary Hypertension Is Associated With Increased Mortality: A Systematic Review and Meta-Analysis
Dhaval Kolte et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
A Potential Link Between Oxidative Stress and Endothelial-to-Mesenchymal Transition in Systemic Sclerosis
Duong Thi Bich Thuan et al.
FRONTIERS IN IMMUNOLOGY (2018)
Prevalence of auto-antibodies associated to pulmonary arterial hypertension Cheek for in scleroderma - A review
Jose Pedro L. Nunes et al.
AUTOIMMUNITY REVIEWS (2018)
Fourth Universal Definition of Myocardial Infarction (2018)
Kristian Thygesen et al.
CIRCULATION (2018)
Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
Lisa M. Rice et al.
ARTHRITIS RESEARCH & THERAPY (2018)
A Proteome-Derived Longitudinal Pharmacodynamic Biomarker for Diffuse Systemic Sclerosis Skin
Lisa M. Rice et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants
Peter Willeit et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Endothelial cell-specific activation of transforming growth factor-β signaling in mice induces cutaneous, visceral, and microvascular fibrosis
Peter J. Wermuth et al.
LABORATORY INVESTIGATION (2017)
Epidemiology and treatment of pulmonary arterial hypertension
Edmund M. T. Lau et al.
NATURE REVIEWS CARDIOLOGY (2017)
Functional autoantibodies targeting G protein-coupled receptors in rheumatic diseases
Otavio Cabral-Marques et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis
Jerome Avouac et al.
ARTHRITIS & RHEUMATOLOGY (2017)
The Influence of Age on Hemodynamic Parameters During Rest and Exercise in Healthy Individuals
Emil Wolsk et al.
JACC-HEART FAILURE (2017)
Pulmonary hypertension associated with antiphospholipid antibody: Call for a screening tool?
Rukma Parthvi et al.
INTRACTABLE & RARE DISEASES RESEARCH (2017)
Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension A Comparison of Demographic, Hemodynamic, and SRI Characteristics and Outcomes
Sheila Ramjug et al.
CHEST (2017)
Antiphospholipid antibodies can identify lupus patients at risk of pulmonary hypertension: A systematic review and meta-analysis
Stephane Zuily et al.
AUTOIMMUNITY REVIEWS (2017)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program
Bradley A. Maron et al.
CIRCULATION (2016)
Biomarkers of tissue remodeling predict survival in patients with pulmonary hypertension
Svenja L. Tiede et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis
Kouki Nakamura et al.
JOURNAL OF DERMATOLOGY (2016)
Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
Sergio A. Jimenez et al.
MATRIX BIOLOGY (2016)
Serum uric acid as a marker of microvascular damage in systemic sclerosis patients
Antonietta Gigante et al.
MICROVASCULAR RESEARCH (2016)
OsteopontinA Master Regulator of Epithelial-Mesenchymal Transition
Anai N. Kothari et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension
Robert B. Good et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Serum Endostatin Is a Genetically Determined Predictor of Survival in Pulmonary Arterial Hypertension
Rachel Damico et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Mechanical Stress and the Induction of Lung Fibrosis via the Midkine Signaling Pathway
Rang Zhang et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis
C. Corallo et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2015)
Biomarkers of pulmonary hypertension in patients with scleroderma: a case-control study
Zsuzsanna McMahan et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study
Silje Reiseter et al.
ARTHRITIS RESEARCH & THERAPY (2015)
GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective
Ramu Adela et al.
JOURNAL OF DIABETES RESEARCH (2015)
Anti-Endothelin Receptor Type A Autoantibodies in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension
Li Guo et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Clinical and laboratory profiles of 136 systemic sclerosis patients with and without echocardiographically detected pulmonary hypertension
J. -H. Tao et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2015)
Vascular Receptor Autoantibodies in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis
Mike O. Becker et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
J. Gerry Coghlan et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Evidence for the Involvement of Type I Interferon in Pulmonary Arterial Hypertension
Peter M. George et al.
CIRCULATION RESEARCH (2014)
Serum endothelin-1 and NT-proBNP, but not ADMA, endoglin and TIMP-1 levels, reflect impaired right ventricular function in patients with systemic sclerosis
Michal Ciurzynski et al.
CLINICAL RHEUMATOLOGY (2014)
Detection of High-Sensitivity Troponin in Outpatients With Stable Pulmonary Hypertension Identifies a Subgroup at Higher Risk of Adverse Outcomes
Andrew K. Roy et al.
JOURNAL OF CARDIAC FAILURE (2014)
Arterial stiffness, antiphospholipid antibodies, and pulmonary arterial hypertension in systemic lupus erythematosus
Ji Hyun Lee et al.
JOURNAL OF CARDIOLOGY (2014)
Autoantibodies against platelet-derived growth factor receptor alpha in patients with systemic lupus erythematosus
Kazuhiro Kurasawa et al.
Modern Rheumatology (2014)
Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
L. van Bon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Key Role of the Endothelial TGF-β/ALK1/Endoglin Signaling Pathway in Humans and Rodents Pulmonary Hypertension
Benoit Gore et al.
PLOS ONE (2014)
Improvement of plasma endothelin-1 and nitric oxide in patients with systemic sclerosis by bosentan therapy
Shin-ya Kawashiri et al.
RHEUMATOLOGY INTERNATIONAL (2014)
Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort
L. Miller et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2014)
Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients
Jeannine Guenther et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis
Angela Kill et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Functional implications of IgG anti-endothelial cell antibodies in pulmonary arterial hypertension
Steven J. Arends et al.
AUTOIMMUNITY (2013)
IL-1β and TGFβ2 synergistically induce endothelial to mesenchymal transition in an NFκB-dependent manner
Monika Maleszewska et al.
IMMUNOBIOLOGY (2013)
Different actions of endothelin-1 on chemokine production in rat cultured astrocytes: reduction of CX3CL1/fractalkine and an increase in CCL2/MCP-1 and CXCL1/CINC-1
Yutaka Koyama et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Agonistic anti-ICAM-1 antibodies in scleroderma: Activation of endothelial pro-inflammatory cascades
Sabine I. Wolf et al.
VASCULAR PHARMACOLOGY (2013)
Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage
Mirko Manetti et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Pulmonary vascular resistances during exercise in normal subjects: a systematic review
G. Kovacs et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Inflammatory Myopathies With Anti-Ku Antibodies A Prognosis Dependent on Associated Lung Disease
Aude Rigolet et al.
MEDICINE (2012)
Human Pentraxin 3 (PTX3) as a Novel Biomarker for the Diagnosis of Pulmonary Arterial Hypertension
Yuichi Tamura et al.
PLOS ONE (2012)
Baseline vWF factor predicts the development of elevated pulmonary artery pressure in systemic sclerosis
Theresa Barnes et al.
RHEUMATOLOGY (2012)
Involvement of functional autoantibodies against vascular receptors in systemic sclerosis
Gabriela Riemekasten et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Screening for Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis Clinical Characteristics at Diagnosis and Long-Term Survival
Marc Humbert et al.
ARTHRITIS AND RHEUMATISM (2011)
Interferon and Alternative Activation of Monocyte/Macrophages in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Romy B. Christmann et al.
ARTHRITIS AND RHEUMATISM (2011)
The Origin of the Myofibroblast in Fibroproliferative Vasculopathy: Does the Endothelial Cell Steer the Pathophysiology of Systemic Sclerosis?
Mirko Manetti et al.
ARTHRITIS AND RHEUMATISM (2011)
Increased Expression of Growth Differentiation Factor-15 in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Christina A. Meadows et al.
CHEST (2011)
Osteopontin in Patients With Idiopathic Pulmonary Hypertension
Johan M. Lorenzen et al.
CHEST (2011)
High-sensitive troponin T and I are related to invasive hemodynamic data and mortality in patients with left-ventricular dysfunction and precapillary pulmonary hypertension
Kai M. Eggers et al.
CLINICA CHIMICA ACTA (2011)
Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvement
Pia Moinzadeh et al.
EXPERIMENTAL DERMATOLOGY (2011)
EVALUATION OF THE EFFECT OF BOSENTAN TREATMENT ON PROINFLAMMATORY CYTOKINE SERUM LEVELS IN PATIENTS AFFECTED BY SYSTEMIC SCLEROSIS
F. Bellisai et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2011)
Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome
Ayse Cefle et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis
Bradley J. Rabquer et al.
ARTHRITIS RESEARCH & THERAPY (2011)
A Histopathological Study of Pulmonary Hypertension in Connective Tissue Disease
Nobuhito Sasaki et al.
ALLERGOLOGY INTERNATIONAL (2011)
Capillary dimension measured by computer-based digitalized image correlated with plasma endothelin-1 levels in patients with systemic sclerosis
Hyun-Sook Kim et al.
CLINICAL RHEUMATOLOGY (2010)
High-sensitive troponin T: a novel biomarker for prognosis and disease severity in patients with pulmonary arterial hypertension
Arthur Filusch et al.
CLINICAL SCIENCE (2010)
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension
S. C. Mathai et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Comparison of Brain Natriuretic Peptide (BNP) and NT-proBNP in Screening for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis
Lorenzo Cavagna et al.
JOURNAL OF RHEUMATOLOGY (2010)
Limited Systemic Sclerosis Patients with Pulmonary Arterial Hypertension Show Biomarkers of Inflammation and Vascular Injury
Sarah A. Pendergrass et al.
PLOS ONE (2010)
Osteopontin in the development of systemic sclerosis-relation to disease activity and organ manifestation
Johan M. Lorenzen et al.
RHEUMATOLOGY (2010)
Independent Association of Anti-β2-Glycoprotein I Antibodies With Macrovascular Disease and Mortality in Scleroderma Patients
Francesco Boin et al.
ARTHRITIS AND RHEUMATISM (2009)
Increases of Cardiac Troponin in Conditions other than Acute Coronary Syndrome and Heart Failure
Walter E. Kelley et al.
CLINICAL CHEMISTRY (2009)
Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review
G. Kovacs et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Potential biomarkers for detecting pulmonary arterial hypertension in patients with systemic sclerosis
Paola Coral-Alvarado et al.
RHEUMATOLOGY INTERNATIONAL (2009)
Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis
Andriana I Papaioannou et al.
BMC Pulmonary Medicine (2009)
Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension
Nils Nickel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension
F. Iannone et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Role of PDGF in fibrotic diseases and systemic sclerosis
M. Trojanowska
RHEUMATOLOGY (2008)
Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension
T. Dimitroulas et al.
RHEUMATOLOGY (2008)
Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases
Peter Dorfmueller et al.
HUMAN PATHOLOGY (2007)
Antiendothelial cell antibodies in vasculitis and connective tissue disease
C. Belizna et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Anti-endothelial cell antibodies from patients with limited cutaneous systemic sclerosis bind to centromeric protein B (CENP-B)
Amelie Servettaz et al.
CLINICAL IMMUNOLOGY (2006)
Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension
J. Vegh et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2006)
Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension
Mark H. Williams et al.
EUROPEAN HEART JOURNAL (2006)
Early detection of pulmonary arterial hypertension in systemic sclerosis -: A French nationwide prospective multicenter study
E Hachulla et al.
ARTHRITIS AND RHEUMATISM (2005)
Troponin: the biomarker of choice for the detection of cardiac injury
L Babuin et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
The significance of elevated brain natriuretic peptide levels in chronic obstructive pulmonary disease
E Bozkanat et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2005)
Clinical significance of brain natriuretic peptide in primary pulmonary hypertension
HH Leuchte et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
VEGF165b, an inhibitory vascular endothelial growth factor splice variant:: Mechanism of action, in vivo effect on angiogenesis and endogenous protein expression
J Woolard et al.
CANCER RESEARCH (2004)
IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients
PG de la Peña-Lefebvre et al.
CLINICAL IMMUNOLOGY (2004)
Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients
MH Houman et al.
LUPUS (2004)
High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension
D Bonderman et al.
THROMBOSIS AND HAEMOSTASIS (2003)
Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension
A Torbicki et al.
CIRCULATION (2003)
Inflammation in pulmonary arterial hypertension
P Dorfmüller et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Prognostic role of brain natriuretic peptide in acute pulmonary embolism
N Kucher et al.
CIRCULATION (2003)
Hyperuricemia as a prognostic factor in pulmonary arterial hypertension
D Bendayan et al.
RESPIRATORY MEDICINE (2003)
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
D Mukerjee et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Plasma brain natriuretic peptide as a noninvasive marker for efficacy of pulmonary thromboendarterectomy
N Nagaya et al.
ANNALS OF THORACIC SURGERY (2002)
Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor
C Atkinson et al.
CIRCULATION (2002)
Extracellular signal-regulated kinase plays an essential role in endothelin-1-induced homotypic adhesion of human neutrophil granulocytes
L Jozsef et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival
AJ MacGregor et al.
RHEUMATOLOGY (2001)
Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells
C Lunardi et al.
NATURE MEDICINE (2000)
Soluble thrombomodulin concentration is raised in scleroderma associated pulmonary hypertension
RJ Stratton et al.
ANNALS OF THE RHEUMATIC DISEASES (2000)
Share Paper
